4,5,6,9-TETRAHYDRO-11,13-DIHYDROXY-4-METHYL-2H-3-BENZOXACYCLODODECIN-2,10(1H)-DIONE, (4S,7E)-
UNII S9X2ZC22HW
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,5,6,9-tetrahydro-11,13-dihydroxy-4-methyl-2h-3-benzoxacyclododecin-2,10(1h)-dione, (4s,7e)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9X2ZC22HW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 631914-48-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H18O5 ZWRCIODUEDCNMZ-YWNRKNDBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,5,6,9-tetrahydro-11,13-dihydroxy-4-methyl-2h-3-benzoxacyclododecin-2,10(1h)-dione, (4s,7e)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.